ACHE and Alzheimer disease: In the last years, our research groups have synthesized and assayed new multi-functional ligands with chelating abilities towards Cu2+ and Zn2+, potentially useful in the AD treatment based on the framework of the acetylcholinesterase (AChE) inhibitor Donepezil and 2-hydroxyphenylbenzimidazole [19,20,21].